Search results
Mar 2015. Mario Amendola. Bas van Steensel. In mammals, the nuclear lamina interacts with hundreds of large genomic regions, termed lamina-associated domains (LADs) that are generally in a ...
Mario AMENDOLA, PhD 1 CURRICULUM VITAE (updated 2023) PERSONAL DATA Name: Mario Amendola Nationality: Italian E-mail: mamendola@genethon.fr WORKING EXPERIENCE Nov 2022-pres Associate Professor of Molecular Biology, University of Foggia, Italy Dec 2016-pres Chargé de Recherche de 1ère classe (CR1) INSERM, UMR_S951, Evry, FR.
The team is mainly focused on the development of efficient and safe gene editing techniques to treat rare genetic diseases in vivo and ex vivo. The team’s researchers Mario Amendola, PhD Team leaderInserm Researcher Expertise: gene therapy, gene editing, viral vectors, expression of hematopoietic stem cells 0000-0002-1188-8856 Guillaume Corre,PhD Research engineer, bioinformatician Expertise ...
Mario Amendola 1 2 , Aurélie Bedel 3 4 5 , Ana Buj-Bello 1 2 , Mathieu Carrara 6 , Jean-Paul Concordet 6 , Giacomo Frati 7 8 , David Gilot 9 , Carine Giovannangeli 6 , Alejandra Gutierrez-Guerrero 10 , Marine Laurent 1 2 , Annarita Miccio 7 8 , François Moreau-Gaudry 3 4 5 , Célia Sourd 1 2 , Julien Valton 11 , Els Verhoeyen 10 12
Specifically, by inserting transgenes under the control of the endogenous α or β-globin promoter, we aim to redirect a fraction of the striking globin synthesis capacity of erythroid cells (~7.2gr/day) for therapeutic protein expression without interfering with physiological erythropoiesis. The combination of robust transcription and the ...
Mario Amendola created his "Therapeutic Genome Editing" team within Integrare with funding from Atige
<link rel="stylesheet" href="styles.0e4fce986182b72f.css"> Please enable JavaScript to continue using this application.
